Hexarelin versus other secretagogues: what the comparisons really show
A larger growth hormone response does not automatically mean better results. The direct comparisons reveal a narrower, more useful picture.
Read articleFor informational and research purposes only.
Research, explained. Explore peptides, supplements, hormone health, longevity and red light therapy with clear, practical breakdowns of what the studies actually tell us.
Metabolism, recovery and emerging research
A larger growth hormone response does not automatically mean better results. The direct comparisons reveal a narrower, more useful picture.
Read articleTrace DSIP's short half-life claims back to animal and blood-sample experiments, and see why they cannot predict the duration of a sleep benefit.
Read articleUnderstand GLORY-1's paired DXA scans and the difference between lean mass, muscle strength and the proportion of weight lost as fat.
Read articleA useful tendon trial must separate pain relief from recovery of strength and structure. Here is what the human evidence and new shoulder registration show.
Read articleHuman MOTS-c exercise studies measured the body's own peptide; rodent treatment and analogue results answer different performance questions.
Read articleA small study found higher humanin in centenarians’ children. Other human studies complicate the story: context matters more than a simple high-or-low target.
Read articleA small trial found higher satisfaction with GHK-Cu after laser resurfacing, but no significant added objective benefit. What does that mean for aftercare?
Read articleRepeated GHRP-6 studies show how GH secretion can persist while a later challenge response shrinks. Understand attenuation without inventing a cycle.
Read articleBinding proteins help explain LR3's experimental activity, but weaker binding does not establish a longer human half-life or predictable benefits.
Read articleCreatine kinase, tissue repair and restored function answer different questions. Here is how to read MGF recovery research without skipping those differences.
Read articleBiofilm prevention, biomass and viable organisms are different outcomes. Explore what LL-37 experiments show and what clinical treatment claims still need.
Read articleA small clinic study found higher IGF-1 with three peptides plus testosterone. Learn what it measured and why it cannot isolate sermorelin's benefit.
Read article277–288 of 323 articles